AU5583298A - Controlled release composition - Google Patents

Controlled release composition

Info

Publication number
AU5583298A
AU5583298A AU55832/98A AU5583298A AU5583298A AU 5583298 A AU5583298 A AU 5583298A AU 55832/98 A AU55832/98 A AU 55832/98A AU 5583298 A AU5583298 A AU 5583298A AU 5583298 A AU5583298 A AU 5583298A
Authority
AU
Australia
Prior art keywords
controlled release
composition
release composition
active material
biologically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU55832/98A
Other languages
English (en)
Inventor
Niels Krog
Kare Larsson
Helena Ljusberg-Wahren
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandberg Development AB
Original Assignee
GS Development AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GS Development AB filed Critical GS Development AB
Publication of AU5583298A publication Critical patent/AU5583298A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU55832/98A 1997-01-13 1998-01-08 Controlled release composition Abandoned AU5583298A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9700061A SE511313C2 (sv) 1997-01-13 1997-01-13 Komposition med reglerad frisättning innefattande fettsyraester av diacylglycerol
SE9700061 1997-01-13
PCT/SE1998/000009 WO1998030206A1 (en) 1997-01-13 1998-01-08 Controlled release composition

Publications (1)

Publication Number Publication Date
AU5583298A true AU5583298A (en) 1998-08-03

Family

ID=20405393

Family Applications (1)

Application Number Title Priority Date Filing Date
AU55832/98A Abandoned AU5583298A (en) 1997-01-13 1998-01-08 Controlled release composition

Country Status (9)

Country Link
US (1) US6660278B1 (https=)
EP (1) EP0954287B1 (https=)
JP (1) JP2001508773A (https=)
AT (1) ATE243024T1 (https=)
AU (1) AU5583298A (https=)
CA (1) CA2277377C (https=)
DE (1) DE69815659T2 (https=)
SE (1) SE511313C2 (https=)
WO (1) WO1998030206A1 (https=)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020153508A1 (en) 2000-06-29 2002-10-24 Lynch Matthew Lawrence Cubic liquid crystalline compositions and methods for their preparation
ES2561108T3 (es) * 2001-10-19 2016-02-24 Idexx Laboratories, Inc. Composiciones inyectables para la liberación controlada de compuesto farmacológicamente activo
US6946137B2 (en) * 2001-10-19 2005-09-20 Idexx Laboratories, Inc. Methods for the controlled delivery of pharmacologically active compounds
US7439268B2 (en) * 2003-07-18 2008-10-21 Idexx Laboratories Compositions containing prodrugs of florfenicol and methods of use
US20050049210A1 (en) * 2003-08-27 2005-03-03 Idexx Laboratories, Inc. Methods for the controlled delivery of pharmacologically active compounds
WO2005117830A1 (en) * 2004-06-04 2005-12-15 Camurus Ab Liquid depot formulations
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US8263102B2 (en) 2004-09-28 2012-09-11 Atrium Medical Corporation Drug delivery coating for use with a stent
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
WO2006036984A2 (en) 2004-09-28 2006-04-06 Atrium Medical Corporation Stand-alone film and methods for making the same
US9801982B2 (en) 2004-09-28 2017-10-31 Atrium Medical Corporation Implantable barrier device
US20060127437A1 (en) * 2004-12-13 2006-06-15 Misty Anderson Kennedy Semisolid system and combination semisolid, multiparticulate system for sealing tissues and/or controlling biological fluids
US8535709B2 (en) * 2004-12-13 2013-09-17 Southeastern Medical Technologies, Llc Agents for controlling biological fluids and methods of use thereof
US20070059350A1 (en) * 2004-12-13 2007-03-15 Kennedy John P Agents for controlling biological fluids and methods of use thereof
US8288348B2 (en) * 2005-07-13 2012-10-16 Allergan, Inc. Cyclosporin compositions
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
CA2626030A1 (en) 2005-10-15 2007-04-26 Atrium Medical Corporation Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
US9492596B2 (en) 2006-11-06 2016-11-15 Atrium Medical Corporation Barrier layer with underlying medical device and one or more reinforcing support structures
WO2008057328A2 (en) 2006-11-06 2008-05-15 Atrium Medical Corporation Tissue separating device with reinforced support for anchoring mechanisms
US7550625B2 (en) * 2007-10-19 2009-06-23 Idexx Laboratories Esters of florfenicol
WO2010063080A1 (en) 2008-12-05 2010-06-10 Commonwealth Scientific And Industrial Research Organisation Amphiphile prodrugs
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
WO2011050388A1 (en) * 2009-10-30 2011-05-05 Monash University Liquid crystal composition and method of use
WO2011145659A1 (ja) * 2010-05-18 2011-11-24 富士フイルム株式会社 カロチノイド含有組成物及びその製造方法
WO2012009707A2 (en) 2010-07-16 2012-01-19 Atrium Medical Corporation Composition and methods for altering the rate of hydrolysis of cured oil-based materials
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
EP3791861A1 (en) 2012-07-26 2021-03-17 Camurus AB Opioid formulations
NZ704012A (en) 2012-07-26 2017-09-29 Camurus Ab Opioid formulations
BR112020010519A2 (pt) 2017-11-27 2020-10-20 Umecrine Cognition Ab formulação farmacêutica de oxima de 3¿lfa-etinil-3¿eta-hidroxiandrostan-17-ona
WO2019204869A1 (en) 2018-04-26 2019-10-31 NanoMed Holdings Pty Ltd Gemcitabine amphiphile prodrugs
SG11202107877WA (en) 2018-06-21 2021-08-30 NanoMed Holdings Pty Ltd Platinum-based amphiphile prodrugs
JP7646013B2 (ja) * 2021-01-29 2025-03-14 イーオーイー オレオ ゲーエムベーハー ポリグリセロール脂肪酸エステル含有組成物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5321393B2 (https=) * 1974-10-19 1978-07-03
US5264460A (en) * 1988-05-30 1993-11-23 Deutsche Solvay-Werke Gmbh Process for preparing nonionic surfactants
GB2222770B (en) 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
IE65045B1 (en) * 1990-04-28 1995-10-04 Takeda Chemical Industries Ltd Granulated preparations and method of producing the same
AU668509B2 (en) * 1991-04-19 1996-05-09 Affinity Biotech, Inc. Convertible microemulsion formulations
SE518578C2 (sv) * 1994-06-15 2002-10-29 Gs Dev Ab Lipidbaserad komposition
US6013269A (en) * 1994-10-12 2000-01-11 The Procter & Gamble Company Cosmetic make-up compositions
SE504582C2 (sv) 1995-07-06 1997-03-10 Gs Dev Ab Cyklosporinkomposition baserad på en L2-fas
CZ288739B6 (cs) * 1996-08-01 2001-08-15 Galena, A. S. Cyklosporin obsahující léčivé přípravky

Also Published As

Publication number Publication date
SE9700061L (sv) 1998-07-14
DE69815659D1 (de) 2003-07-24
ATE243024T1 (de) 2003-07-15
EP0954287B1 (en) 2003-06-18
SE9700061D0 (sv) 1997-01-13
US6660278B1 (en) 2003-12-09
DE69815659T2 (de) 2004-04-29
JP2001508773A (ja) 2001-07-03
EP0954287A1 (en) 1999-11-10
SE511313C2 (sv) 1999-09-06
CA2277377C (en) 2007-12-18
CA2277377A1 (en) 1998-07-16
WO1998030206A1 (en) 1998-07-16

Similar Documents

Publication Publication Date Title
AU5583298A (en) Controlled release composition
AU5905694A (en) Compositions for controlled release of biologically active TGF-beta
MY110765A (en) Compositions containing cholesteryl esters of unsaturated fatty acids
CA2222567A1 (en) High viscosity liquid controlled biologically active delivery system
CA2234833A1 (fr) Composition comprenant un milieu de culture de micro-organisme et utilisation
ES2166788T3 (es) Procedimiento para producir una sustancia.
AU3356297A (en) Thermoplastically processible starch or starch derivative polymer mixtures
PL323176A1 (en) Esters of fatty acids as biologically active compounds
EP0152281A3 (en) Transdermal formulation of nicardipine hydrochloride
DE69836491D1 (de) Fibrinmikrokugeln und deren verwendungen
AU6421594A (en) High release solid preparation, preparation and use thereof
WO1999013864A3 (en) Solid solution beadlet
AU4835396A (en) Composition containing nucleic acids, preparation and use
BR9808668A (pt) Suspensão aquosa de microcápsulas compreendendo um material biologicamente ativo, e, processos para preparação de uma suspensão aquosa de microcápsulas aderentes e para aplicação de microcápsulas em um substrato pretendido
EP1224940A8 (de) Flüssige Interferon-Beta Formulierungen
MX9700511A (es) Inhibidores de spla2 de indolizina.
EP1674565A3 (en) Method for enhancing enzyme activity at elevated temperature
AU2387795A (en) Culture medium for maintaining viability of mammalian cells
EP0294520A1 (en) Process for preparing enzyme preparation
AU5993698A (en) Additive composition for plant protection
AU1911999A (en) Methods and compositions for treating diabetes
CA2263557A1 (en) Implant consisting of a carrier material containing medical substances and method to produce such an implant
CA2039869A1 (en) Percutaneous-administration-type pharmaceutical preparation of nitroglycerin
AU1576092A (en) Improved retard systems for delayed release of medical and/or biological valuable substances from a depot-carrier material
ZA923486B (en) Penetration enhancing substance